|
Status |
Public on Nov 27, 2023 |
Title |
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance [scRNA-seq] |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Other
|
Summary |
Immune cells were isolated from the lungs of mice bearing KEAP1 mutant or wildtype tumors. We found that in KEAP1 mutant tumors there is a reduction in CD103 DCs and early activated T cells as well as an increase in exhausted CD8 T cells in comparison to WT controls.
|
|
|
Overall design |
KEAP1 mutant (n=1) or wildtype (n=1) murine KP lung cancer cells were injected IV into C57BL/6 mice. Lungs were harvested and extravascular CD45 cells were sorted for scRNA-seq. Samples were stained with hashtag antibodies. Libraries were generated for gene expression, hashtags, and TCR sequencing and were then sequenced.
|
|
|
Contributor(s) |
Zavitsanou AM, Pillai R, Hao Y, Tsirigos A, Koralov S, Papagiannakopoulos T |
Citation(s) |
37889752 |
|
Submission date |
Aug 22, 2023 |
Last update date |
Nov 27, 2023 |
Contact name |
Yuan Hao |
Organization name |
NYU Langone Health
|
Street address |
Laura and Isaac Perlmutter Cancer Center
|
City |
New York |
ZIP/Postal code |
10016 |
Country |
USA |
|
|
Platforms (1) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
Samples (4)
|
|
This SubSeries is part of SuperSeries: |
GSE241482 |
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. |
|
Relations |
BioProject |
PRJNA1008265 |